In this video the CEO of Biovian, Knut Ringbom, presents an overview of the year 2020, especially discussing the latest developments in the company. “Over the last year, we have experienced a lot of positive …
The therapeutic possibilities of cell and gene therapy are very appealing. The possibility to use a Viral Vector to carry the therapeutic gene into the target cells or to initiate cell transduction holds the potential …
Biovian, a Nordic Bio-CDMO is presented in the Biopharma Dealmakers’ June edition that focuses on next-generation therapeutics. The article describes Biovian’s concept of a true One-Stop-Shop that covers both the supply chain and the value chain.
